𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacokinetics of tocainide in patients with renal dysfunction and during haemodialysis

✍ Scribed by U. Wiegers; P. Hanrath; K. H. Kuck; A. Pottage; C. Graffner; J. Augustin; M. Runge


Publisher
Springer
Year
1983
Tongue
English
Weight
572 KB
Volume
24
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Cisplatin pharmacokinetics in a patient
✍ Prestayko, Archie W. ;Luft, Fredrich C. ;Einhorn, Lawrence ;Crooke, Stanley T. πŸ“‚ Article πŸ“… 1978 πŸ› John Wiley and Sons 🌐 English βš– 311 KB

Plasma and urine platinum concentrations were measured by atomic absorption spectrophotometry during a three-day course of cisdiamminedichloroplatinum (DDP, cis-platinum, cisplatin) therapy in a patient with acute renal failure who was being treated with hemodialysis. Twenty-four hour urine collecti

The pharmacokinetics of fluconazole duri
✍ S. Oono; K. Tabei; T. Tetsuka; Y. Asano πŸ“‚ Article πŸ“… 1992 πŸ› Springer 🌐 English βš– 199 KB

We have studied the pharmacokinetics of fluconazole in five patients on long-term haemodialysis. The single-pass extraction rate of the dialyzer was 59 (3.5)% (n = 4), and the serum concentration was reduced by haemodialysis for 3 or 4 h by 26 (3.2)% (n = 5) and 39 (2.2)% (n = 9) respectively. The e

Oral pharmacokinetics of pirenzepine in
✍ T. MacGregor; K. Matzek; J. Keirns; M. Vinocur; A. Chonko πŸ“‚ Article πŸ“… 1990 πŸ› Springer 🌐 English βš– 215 KB

The pharmacokinetic properties of pirenzepine following administration of a single, 50 mg oral dose were evaluated in three groups of subjects: group I, end stage renal disease requiring maintenance haemodialysis (CLCR 0 to 10 ml.min-1); group II, moderate renal insufficiency (CLCR 10 to 30 ml.min-1